Clinical Trial Update: Novel Augmentation of DAOIB and Antioxidant for Early Dementia [Phase 2]

View source ↗

Summary

This Phase 2 trial update describes a novel augmentation of DAOIB with an unspecified antioxidant for early dementia and is currently recruiting, including part…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Antioxidant (unspecified)
• DAOIB

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Status: RECRUITING